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450a Tuesday, February 5, 2013double-labeled with 2-(4’-(2’’-iodoacetamido)phenyl)aminonaphthalene-6-
sulfonic acid (IAANS) was greater at higher temperatures, i.e. 0.11, 0.25 and
0.66 log units at 21, 30 and 45C respectively. In cardiac skinned fibers at
higher temperatures, Ca2þ binding affinity (-log Ca50) was further increased
for D145E (from pCa50 5.5550.01 at 15C to 6.3450.02 at 30C) than for
WT (pCa50 5.3950.01 at 15C to 5.9650.04 at 30C), so that DpCa50 mea-
sured at different temperatures increased in a linear fashion. Maximal tension
(P0) was markedly lower for D145E compared to WT at 30C. These data in-
dicate that D145E´s instability dictates its impaired function within the physio-
logical milieu. NIH-HL103840 (JRP)2303-Pos Board B322
Remote Ischemic Conditioning Restores Contractile defect Following
Ischemia by Reversing Ischemia-Induced Decreases in Phosphorylation
of Sarcomeric Proteins
Young S. Han, Ozgur Ogut.
Mayo Clinic College of Medicine, Rochester, MN, USA.
Non-invasive remote ischemic conditioning, repetitive brief ischemia of the
arm or leg through alternating inflation and deflation of a blood-pressure
cuff, has been demonstrated to produce cardioprotection in animal models
and in clinical studies. Our previous study using an in vivo rat ischemia model
demonstrated a decrease in maximal force per cross-sectional area (Fmax) and
the rate constant of force activation (kact) following flash photolysis of caged
Ca2þ (NP-EGTA), which correlated with a decrease in phosphorylation of tro-
ponin I (TnI) and myosin binding protein-C (MyBP-C), important regulators of
muscle contraction and targets of the cAMP-dependent protein kinase (PKA)
upon b-adrenergic receptor (b-AR) stimulation. Therefore, we hypothesized
that remote ischemic conditioning would mitigate the decrease in mechanical
function following acute ischemia by reversing ischemia-derived decreases
in phosphorylation of sarcomeric proteins and/or of PKA subunits. To test
this hypothesis, we examined Fmax, kact, and phosphorylation status of
MyBP-C, TnT, TnI, and PKA subunits in control, ischemic and conditioned
rat myocardia. Remote ischemic conditioning was simultaneously applied to
experimental rats undergoing 30-min acute myocardial ischemia with LAD
ligation by executing 3 cycles of 5-min inflation and deflation of a blood-
pressure cuff mounted on the left hind limb. Our data show that remote ische-
mic conditioning significantly blunts the reduction in Fmax (72.5 5 4.9 vs
53.7 5 3.4 vs 64.9 5 2.4 mN/mm2; control vs ischemic vs conditioned,
n=9; P< 0.05) and in kact (24.45 1.9 vs 19.15 1.0 vs 23.15 1.1 s
1; control
vs ischemic vs conditioned, n=9; P < 0.05), which correlates with reversal of
ischemia-derived decreases in phosphorylation of target proteins of PKA.
These data suggest that remote conditioning merits additional study for its
beneficial role in ischemia-induced myocardial dysfunction.2304-Pos Board B323
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Myosin Binding Protein-C (MyBP-C), expressed in striated muscles, is a thick
filament associated protein that plays important roles in thick filament assembly
and stabilization, and the modulation of actomyosin cross-bridges formation.
Several studies have implicated MyBP-C in the development of cardiac and
recently skeletal myopathies, underlining its importance in normal sarcomeric
function. Mutations in the slow skeletal isoform of MyBP-C (sMyBP-C) have
been causally linked to severe and lethal forms of arthrogryposis, a family of
neuromuscular diseases. Two missense mutations within MYBPC1, the gene
that encodes sMyBP-C, located within the NH2-terminal M-motif (W236R)
and the COOH-terminal immunoglobulin (Ig) C8 domain (Y856H) have
been linked to the development of distal arthrogryposis type-1 (DA-1), a skel-
etal muscle disorder characterized by contractures of the distal limbs. Here we
explore the molecular defects that underlie the development of DA-1. using
a combination of in vitro binding and motility assays, we show that the pres-
ence of the W236R mutation abolishes the ability of the NH2-terminus to mod-
ulate the formation of actomyosin cross-bridges, while the presence of the
Y856H mutation inhibits Ig domains C8-C10 from interacting with native
myosin filaments. Our findings therefore suggest that distinct mechanisms
may underlie the pathogenesis of DA-1 myopathy depending on the location
of the individual mutation within sMyBP-C. We are currently examining the
effects of overexpressing mutant sMyBP-C proteins carrying either the
W236R or the Y856H mutation in a sMyBP-C-null background, via in vivo
gene transfer. In summary, our studies are the first to provide a mechanistic
interpretation of the pathogenesis of distal arthrogryposis.2305-Pos Board B324
How Muscle Exploits the Steady State to Regulate Contraction
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Activation of muscle requires myosin binding. The active state of muscle is sta-
bilized by high affinity rigor bonds at equilibrium but, the steady-state catalytic
cycle of myosin ATPase decreases the lifetime of the myosin interaction by
several orders of magnitude. Low myosin affinity could be a justification for
including Ca2þ binding states in a model of activation. Our work supports
a simple model for steady state activation, namely, the regulatory protein tropo-
myosin (Tm) exists in just two states, ground (C) and excited (M), separated by
an energy barrier which can be overcome by interaction with myosin. The elon-
gated shape of Tm allows for multiple potential myosin binding partners (Ui).
During its strong binding phase of the catalytic cycle, any one myosin (U1)
combines with C to form M by an equilibrium pathway. At time, t=0, M prob-
ability, PM=1. Although U1 most likely decays by a non-equilibrium rate (i.e.,
ATP binding), the lifetime of PM is constant. For t>0, before M decays to C,
interaction with Ui in the strong binding phase can restore PM=1. We show
that an analytical function (M function) is fully derived from the combination
of equilibrium and steady state pathways and the additional opportunities
(second chances) to restore PM=1 depend on the rate at which Ui transitions
into the strong binding phase. When Ca2þ is introduced as a mass action reg-
ulator of the U or C supply, the M function takes the general form of the
Hill equation, which is widely employed for fitting the steady state response
of muscle to Ca2þ. We show by simulations that stochastic events predicted
by a second chance mechanism are consistent with solutions to the M function.
Our results justify kinetic experiments that focus specifically on M.
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Troponin I Serine 150 Phosphorylation Inhibits pH-Induced Troponin
Calcium Desensitization
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A hallmark of cardiac ischemia is decreased intracellular pH which can affect
a number of cellular processes. Such an acidic environment alters cardiac tro-
ponin (Tn) myofilament regulation to decrease the Ca2þ sensitivity of force
production. Tn also undergoes cardiac ischemic-induced AMPK troponin I
(TnI) Ser-150 phosphorylation. We recently characterized the effect of TnI
Ser-150 phosphorylation demonstrating it to increase myofilament Ca2þ sensi-
tivity and blunt TnI PKA phosphorylation-induced desensitization. The effect
of an acidic environment on Tn myofilament regulation in the presence of
the ischemic-induced TnI Ser-150 phosphorylation is unknown. In this study
we investigate the effect of pH on myofilament regulation in the presence of
TnI Ser-150 phosphorylation. Myofilament regulation was determined by mea-
suring troponin C Ca2þ binding properties at normal and acidic pH. Results
demonstrate acidic pH decreases steady-state Ca2þ binding to troponin C in
thin filaments reconstituted with either WT or Ser-150 pseudo-phosphorylated
TnI (Tn S150D) such that Tn S150D Ca2þ sensitivity at pH 6.5 is similar to WT
at pH 7. Furthermore, while Tn S150D slowed Ca2þ dissociation compared to
Tn WT at pH 7.0, decreasing the pH to 6.5 did not further alter isolated Tn
S150D Ca2þ dissociation indicating a lack of pH to modulate Tn Ca2þ disso-
ciation kinetics. Thin filament dissociation kinetics are ongoing. We conclude
that TnI Ser-150 phosphorylation imparts resistance to acidic pH induced myo-
filament Ca2þ desensitization similar to that present during ischemia without
alteration of Tn Ca2þ dissociation. Future investigations are aimed at examin-
ing the effect of TnI Ser-150 phosphorylation in the presence of TnI Ser-23/24
phosphorylation at low pH.
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Elevated levels of inorganic phosphate (Pi) and hydrogen ions (H
þ) are putative
agents of muscle fatigue. However, the molecular mechanisms underlying their
inhibitory action on the contractile proteins remains unclear. To gain mechanis-
tic insight into the effects of these ions on the myofilament function, we studied
their impact on the velocity-pCa relationship in an in vitro motility assay.
In this assay, actin filaments reconstituted with fast skeletal troponin (Tn)
and tropomyosin (Tm) moved on a coverslip surface coated with skeletal
myosin. At saturating Ca2þ (pCa5), decreasing the pH from 7.4 to 6.8 and
